EGFR and non-small cell lung carcinoma: Recently, p53, known to function as a negative regulator of PI3K gene transcription, was shown to regulate the fate of NSCLC cells by blocking EGFR/PI3K/AKT signaling through crosstalk with AKT via feedback loops [84].